5VH3
Crystal structure of Fab fragment of the anti-TNFa antibody infliximab in a C-centered orthorhombic crystal form
Summary for 5VH3
Entry DOI | 10.2210/pdb5vh3/pdb |
Related | 5VH4 5VH5 |
Descriptor | Infliximab Fab Heavy Chain, Infliximab Fab Light Chain, 1,2-ETHANEDIOL, ... (4 entities in total) |
Functional Keywords | antibody, fab, infliximab, biosimilar, tnfa, immune system |
Biological source | Mus musculus More |
Total number of polymer chains | 4 |
Total formula weight | 95696.17 |
Authors | Mayclin, S.J.,Edwards, T.E.,Lerch, T.F.,Conlan, H.,Sharpe, P. (deposition date: 2017-04-12, release date: 2017-05-03, Last modification date: 2023-10-04) |
Primary citation | Lerch, T.F.,Sharpe, P.,Mayclin, S.J.,Edwards, T.E.,Lee, E.,Conlon, H.D.,Polleck, S.,Rouse, J.C.,Luo, Y.,Zou, Q. Infliximab crystal structures reveal insights into self-association. MAbs, 9:874-883, 2017 Cited by PubMed: 28421849DOI: 10.1080/19420862.2017.1320463 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report